Sentence: Both liposomal doxorubicin ( LD ) and docetaxel ( D ) have a broad range of activity against solid tumors , including advanced pancreatic cancer ( APC ) , as single agents , while their combination has produced encouraging response rates in the treatment of several malignancies .
Drug combination annotation:
[{'class': 'POS', 'spans': ['doxorubicin', 'docetaxel'], 'is_context_needed': False}]